Study Compares Anticoagulants for Antiphospholipid Syndrome

TUESDAY, Oct. 15, 2019 -- In thrombotic antiphospholipid antibody syndrome (APS), rivaroxaban is not noninferior to dose-adjusted vitamin K antagonists (VKAs), according to a study published online Oct. 15 in the Annals of Internal Medicine.
Josep...

Source: Drugs.com - Pharma News - October 15, 2019 Category: Pharmaceuticals Source Type: news